Mirum Targets $500m Sales For Just-Approved Rare Liver Disorder Drug

FDA Green Light For Alagille Syndrome Therapy Livmarli

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.